This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Atrioventricular Block
and you are
over 18
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The SEPTAL-PM study is aimed to compare the right ventricular apical and right ventricular septal position of the right ventricular lead in patients implanted with a pacemaker for conventional anti-bradycardia pacing indications requiring permanent right ventricular pacing ; the primary endpoint is the evolution of the left ventricular ejection fraction assessed by contrast echocardiography at 18-months follow-up.

Provided treatments

  • Device: RV lead
Tris trial is registered with FDA with number: NCT00925691. The sponsor of the trial is Rennes University Hospital and it is looking for 141 volunteers for the current phase.
Official trial title:
Comparison of SEPTal and Apical Pacing Sites in PerManent Right Ventricular Pacing